资讯信息
information相关产品
CAS:219783-77-4|Paclitaxel Impurity O
发布时间:2024-06-05 分享至:
试剂家(www.empireagents.com) - 瑞禧生物旗下试剂品牌。致力于为全球客户提供高性价比的助力药物递送的产品服务。公司的奋斗目标是搭建一个国际知名的药物递送修饰平台,携手高端人才和所有合作伙伴,共同为人类各行各业的事业发展做出贡献!
Catalogue Number:A188120
Chemical Name:Paclitaxel Impurity O
Synonyms:Paclitaxel EP Impurity O; (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (αR,βS)-α-hydroxy-β-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]amino]-benzenepropanoic Acid
Impurity:Paclitaxel EP Impurity O
CAS Number:219783-77-4
Molecular Formula:C₄₉H₅₃NO₁₄
Molecular Weight:879.94
Category:Standards; Pharmaceutical/API Drug Impurities/Metabolites;
Applications:Paclitaxel EP Impurity O is an impurity of Paclitaxel (P132500), an antineoplastic. Paclitaxel is used to treat patients with lung, ovarian, breast cancer, head and neck cancer, and advanced forms of Kaposi's sarcoma.
References:Letourneau, P.C., et al.: J. Cell Biol., 98, 1355 (1984), Manfredi, J.J., et al.: Pharmacol. Ther., 25, 83 (1984), Danesi, R., et al.: Mol. Pharmacol., 47, 1106 (1995), Markman, M., et al.: Expert. Opin. Pharmacother., 3, 755 (2002), Stone, G.W., et al.: N. Engl. J. Med., 350, 221 (2004),试剂家(www.empireagents.com)从未停止过技术的拓展与创新。凭借这充满进取的创新精神,我们已经为国内外高校、科研单位、材料研究中心、生物技术制药开发公司等等定制合成了各种功能化试剂,赢得了合作单位的长期信赖。
更多产品推荐:
CAS:157469-74-4|1-[(4-Chlorophenyl)methyl]-1H-pyrazole-4,5-diamine Sulfate
CAS:7379-35-3|4-Chloropyridine Hydrochloride
CAS:100859-99-2|N-(2-Chloropropyl)morpholine Hydrochloride
CAS:14423-79-1|N1-(3-Chloropyrazinyl)-sulfanilamide
CAS:57090-45-6|(R)-(-)-3-Chloro-1,2-propanediol
CAS:7623-09-8|2-Chloropropionyl Chloride
CAS:1219794-98-5|(±)-2-Chloropropionyl-2,3,3,3-d4 Chloride
CAS:59767-24-7|1-(4-Chlorophenyl)-1-phenylethanol
CAS:361197-68-4|11-(2-Chlorophenyl)-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one
CAS:35680-24-1|2-Chloro-6-methylpyridin-3-ol